Nachrichten zur Biotec Pharmacon ASA Aktie

Tromsø, Norway, 17[th] August 2023 – ArcticZymes Technologies (OSE: AZT) reported sales of NOK 28.2 million and an EBITDA of…

ArcticZymes Technologies presents on August 17, 2023 at 08:30 its interim report for the second quarter and first 6 months…

(Tromsø 17 July 2023) ArcticZymes Technologies ASA (OSE:AZT) is pleased to announce the appointment of Michael Akoh as its new…

(Tromsø 06. June 2023) The Annual General Meeting of ArcticZymes Technologies ASA (OSE:AZT) was held today, 06. June 2023 as…

ArcticZymes Technologies presents on May 4, 2023 at 08:30 its interim report for the first quarter of 2023 Speaker at the…

Tromsø, Norway, 03[rd] May 2023 – ArcticZymes Technologies (OSE: AZT) reported sales of NOK 31.2 million and an EBITDA of…

Genovis and ArcticZymes are excited to announce a collaboration to speed up penetration and growth in the Chinese market. The…

(Tromsø, 02 May 2023) ArcticZymes Technologies ASA (OSE:"AZT") has published its Annual Report together with its updated ESG report for 2022. The…

Tromsø, March 22nd 2023 – ArcticZymes Technologies ASA (OSE: AZT) announces that the Board of Directors has today accepted the…

Tromsø, Norway, 16[th] of March 2023 - ArcticZymes Technologies ASA (OSE: AZT) has filed a new patent application within the…

Tromsø (03 February 2023) Jane Theaker, member of the board of directors has today bought 10.044 shares in ArcticZymes Technologies…

ArcticZymes Technologies presents on February 2, 2023 at 08:30 its Q4 and full year 2022 report  followed by an extended…

Tromsø, January 05 2023 – ArcticZymes Technologies ASA (OSE: AZT) announces significant headwinds for the fourth quarter with sales of 28.3…